These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 20172281

  • 1. Evaluation of calprotectin level in intestinal content as an early marker for graft rejection.
    Cagnola H, Scaravonati R, Cabanne A, Bianchi C, Gruz F, Errea A, Zambernardi A, Meier D, Chirdo F, Docena G, Gondolesi G, Rumbo M.
    Transplant Proc; 2010; 42(1):57-61. PubMed ID: 20172281
    [Abstract] [Full Text] [Related]

  • 2. Calprotectin: a novel noninvasive marker for intestinal allograft monitoring.
    Sudan D, Vargas L, Sun Y, Bok L, Dijkstra G, Langnas A.
    Ann Surg; 2007 Aug; 246(2):311-5. PubMed ID: 17667511
    [Abstract] [Full Text] [Related]

  • 3. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 4. Fecal calprotectin level measurements in small bowel allograft monitoring: a pilot study.
    Akpinar E, Vargas J, Kato T, Smith L, Hernandez E, Selvaggi G, Nishida S, Moon J, Island E, Levi D, Ruiz P, Tzakis AG.
    Transplantation; 2008 May 15; 85(9):1281-6. PubMed ID: 18475184
    [Abstract] [Full Text] [Related]

  • 5. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K, Janatková I, Bortlík M, Komárek V, Lukás M.
    Epidemiol Mikrobiol Imunol; 2008 Nov 15; 57(4):147-53. PubMed ID: 19069028
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, Cirillo P, Paparo F, Troncone R.
    Dig Liver Dis; 2004 Jul 15; 36(7):467-70. PubMed ID: 15285526
    [Abstract] [Full Text] [Related]

  • 7. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
    Scarpa M, D'Incà R, Basso D, Ruffolo C, Polese L, Bertin E, Luise A, Frego M, Plebani M, Sturniolo GC, D'Amico DF, Angriman I.
    Dis Colon Rectum; 2007 Jun 15; 50(6):861-9. PubMed ID: 17473939
    [Abstract] [Full Text] [Related]

  • 8. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
    Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, Karoui S, Zouari B, Boubaker J, Kaabachi N, Filali A.
    Eur J Gastroenterol Hepatol; 2010 Mar 15; 22(3):340-5. PubMed ID: 19581809
    [Abstract] [Full Text] [Related]

  • 9. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW, Maestranzi S, Duffy AM, Dewar DH, Forbes A, Bjarnason I, Sherwood RA, Ciclitira P, Nicholls JR.
    Eur J Gastroenterol Hepatol; 2008 Mar 15; 20(3):174-9. PubMed ID: 18301296
    [Abstract] [Full Text] [Related]

  • 10. Fecal calprotectin as a predictor of abnormal colonic histology.
    Shitrit AB, Braverman D, Stankiewics H, Shitrit D, Peled N, Paz K.
    Dis Colon Rectum; 2007 Dec 15; 50(12):2188-93. PubMed ID: 17963005
    [Abstract] [Full Text] [Related]

  • 11. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL, Raivio T, Lindahl H, Savilahti E.
    Scand J Gastroenterol; 2006 Jun 15; 41(6):720-5. PubMed ID: 16716972
    [Abstract] [Full Text] [Related]

  • 12. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
    Johne B, Kronborg O, Tøn HI, Kristinsson J, Fuglerud P.
    Scand J Gastroenterol; 2001 Mar 15; 36(3):291-6. PubMed ID: 11305517
    [Abstract] [Full Text] [Related]

  • 13. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.
    Am J Gastroenterol; 2010 Jan 15; 105(1):162-9. PubMed ID: 19755969
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O, Naumann M, Shastri Y, Povse N, Stein J.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):1035-42. PubMed ID: 17877510
    [Abstract] [Full Text] [Related]

  • 15. Fecal calprotectin in very low birth weight infants.
    Josefsson S, Bunn SK, Domellöf M.
    J Pediatr Gastroenterol Nutr; 2007 Apr 01; 44(4):407-13. PubMed ID: 17414135
    [Abstract] [Full Text] [Related]

  • 16. Fecal calprotectin: assessment of a rapid test.
    Vestergaard TA, Nielsen SL, Dahlerup JF, Hornung N.
    Scand J Clin Lab Invest; 2008 Apr 01; 68(4):343-7. PubMed ID: 17852834
    [Abstract] [Full Text] [Related]

  • 17. Faecal calprotectin in the assessment of Crohn's disease activity.
    Gaya DR, Lyon TD, Duncan A, Neilly JB, Han S, Howell J, Liddell C, Stanley AJ, Morris AJ, Mackenzie JF.
    QJM; 2005 Jun 01; 98(6):435-41. PubMed ID: 15879440
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stool calprotectin monitoring after small intestine transplantation.
    Mercer DF, Vargas L, Sun Y, Moreno AM, Grant WJ, Botha JF, Langnas AN, Sudan DL.
    Transplantation; 2011 May 27; 91(10):1166-71. PubMed ID: 21460762
    [Abstract] [Full Text] [Related]

  • 20. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I.
    Ned Tijdschr Geneeskd; 2003 Nov 29; 147(48):2360-5. PubMed ID: 14677476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.